• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

Chorea drug?


<























This drug, if approved, is another dud. It has zero data versus the same molecule that Lundbeck sold.
After Lundbeck ripped off managed care they love that great generic price.
Better have some amazing HTH data, kid!
 




















LMAO.....are people really this stupid? Obviously they can't read about generic intrusion, bribes, and the entire branded divisions of Teva being laid off. I figure it will be an 800 rep expansion.